Ledger.Open graph →
SEC Form D · filed May 29, 2018

DrugCendR Inc

Offering
$1.5M
Sold
$1.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
LA JOLLA, CA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (3)

Erkki Ruoslahti · La Jolla, CAExecJeffrey C. Hines · Houston, TXExecJosh W. Gravenor · Houston, TXExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗